Latest News

Halting immune response could save brain cells after stroke

A new study in animals shows that using a compound to block the body?s immune response greatly reduces disability after a stroke. The study also showed that particular immune cells -- CD4+ T-cells produce a mediator, called interleukin (IL) -21 that can cause further damage in stroke tissue. Moreover, normal mice, ordinarily killed or disabled by an ischemic stroke, were given a shot of a compound that blocks the action of IL-21. Brain scans and brain sections showed that the treated mice suffered little or no stroke damage.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • CEOs who motivate with 'fightin' words' shoot themselves in the foot

  • Knowledgeable consumers more likely to buy when given fewer options

  • Targeting the brain to treat obesity

  • Early warning sign for babies at risk of autism: Early joint attention predicts later autism symptoms

  • Creating sustainable STEM teacher programs

  • Klotho: neuroprotective against Alzheimer's disease

  • Cell therapy for multiple sclerosis patients: Closer than ever?

  • Computerized ADHD testing

  • Charter schools nationwide more cost-effective, produce greater ROI

  • 'Quack' child psychology practices identified by study

  •